Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England.

× No keyword cloud information.

21 in total

1. Tigecycline treatment of urinary tract infection and prostatitis: case report and literature review.

Authors: Duane Bates; Mike Parkins; Robin Hellweg; Kimberly Gibson; Jennifer M Bugar
Journal: Can J Hosp Pharm Date: 2012-05

2. Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli.

Authors: Jennifer M Adams-Haduch; Brian A Potoski; Hanna E Sidjabat; David L Paterson; Yohei Doi
Journal: Antimicrob Agents Chemother Date: 2009-03-30 Impact factor: 5.191

3. Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Burkholderia Species Isolates from the United States.

Authors: Elise T Zeiser; Scott A Becka; Melissa D Barnes; Magdalena A Taracila; John J LiPuma; Krisztina M Papp-Wallace
Journal: Antimicrob Agents Chemother Date: 2019-03-27 Impact factor: 5.191

Review 4. Clinical management of infections caused by multidrug-resistant Enterobacteriaceae.

Authors: Mercedes Delgado-Valverde; Jesús Sojo-Dorado; Alvaro Pascual; Jesús Rodríguez-Baño
Journal: Ther Adv Infect Dis Date: 2013-04

Review 5. Pharmacokinetics and Pharmacodynamics of Temocillin.

Authors: Kevin Alexandre; Bruno Fantin
Journal: Clin Pharmacokinet Date: 2018-03 Impact factor: 6.447

Review 6. β-Lactams and β-Lactamase Inhibitors: An Overview.

Authors: Karen Bush; Patricia A Bradford
Journal: Cold Spring Harb Perspect Med Date: 2016-08-01 Impact factor: 6.915

7. Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production.

Authors: N T Mutters; S Zimmermann; M Kaase; A Mischnik
Journal: Eur J Clin Microbiol Infect Dis Date: 2015-10-03 Impact factor: 3.267

Review 8. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors: Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal: Clin Microbiol Rev Date: 2018-02-14 Impact factor: 26.132

Review 9. AmpC beta-lactamases.

Authors: George A Jacoby
Journal: Clin Microbiol Rev Date: 2009-01 Impact factor: 26.132

10. In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units.

Authors: Y Glupczynski; T-D Huang; C Berhin; G Claeys; M Delmée; L Ide; G Ieven; D Pierard; H Rodriguez-Villalobos; M Struelens; J Vaneldere
Journal: Eur J Clin Microbiol Infect Dis Date: 2007-11 Impact factor: 3.267